Serum Matrix Metalloproteinase-7 is an independent prognostic biomarker in advanced bladder cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2001-1326
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Serum Matrix Metalloproteinase-7 is an independent prognostic biomarker in advanced bladder cancer ; volume:3 ; number:1 ; day:28 ; month:10 ; year:2014 ; pages:1-6 ; date:12.2014
Clinical and translational medicine ; 3, Heft 1 (28.10.2014), 1-6, 12.2014
- Creator
-
El Demery, Mounira
Demirdjian-Sarkissian, Gaiané
Thezenas, Simon
Jacot, William
Laghzali, Yassine
Darbouret, Bruno
Culine, Stéphane
Rebillard, Xavier
Lamy, Pierre-Jean
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s40169-014-0031-4
- URN
-
urn:nbn:de:101:1-2019080304550824504226
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:22 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- El Demery, Mounira
- Demirdjian-Sarkissian, Gaiané
- Thezenas, Simon
- Jacot, William
- Laghzali, Yassine
- Darbouret, Bruno
- Culine, Stéphane
- Rebillard, Xavier
- Lamy, Pierre-Jean
- SpringerLink (Online service)
Other Objects (12)
SPON1 is an independent prognostic biomarker for ovarian cancer
The role of matrix metalloproteinase-9 as a prognostic biomarker in papillary thyroid cancer
CXCL10 could be a prognostic and immunological biomarker in bladder cancer
CDH22 hypermethylation is an independent prognostic biomarker in breast cancer
Myosteatosis as a novel prognostic biomarker after radical cystectomy for bladder cancer
SIRT4 is an independent prognostic factor in bladder cancer and inhibits bladder cancer growth by suppressing autophagy
Identification of novel therapeutic target and prognostic biomarker in matrix metalloproteinase gene family in pancreatic cancer
Transcriptome sequencing identifies ANLN as a promising prognostic biomarker in bladder urothelial carcinoma
SKA3 is a prognostic biomarker and associated with immune infiltration in bladder cancer
Monocarboxylate Transporter 1 (MCT1) is an independent prognostic biomarker in endometrial cancer
PRR11 is a prognostic biomarker and correlates with immune infiltrates in bladder urothelial carcinoma
Monocyte infiltration is an independent positive prognostic biomarker in vulvar squamous cell carcinoma
SPON1 is an independent prognostic biomarker for ovarian cancer
The role of matrix metalloproteinase-9 as a prognostic biomarker in papillary thyroid cancer
CXCL10 could be a prognostic and immunological biomarker in bladder cancer
CDH22 hypermethylation is an independent prognostic biomarker in breast cancer
Myosteatosis as a novel prognostic biomarker after radical cystectomy for bladder cancer
SIRT4 is an independent prognostic factor in bladder cancer and inhibits bladder cancer growth by suppressing autophagy
Identification of novel therapeutic target and prognostic biomarker in matrix metalloproteinase gene family in pancreatic cancer
Transcriptome sequencing identifies ANLN as a promising prognostic biomarker in bladder urothelial carcinoma
SKA3 is a prognostic biomarker and associated with immune infiltration in bladder cancer
Monocarboxylate Transporter 1 (MCT1) is an independent prognostic biomarker in endometrial cancer
PRR11 is a prognostic biomarker and correlates with immune infiltrates in bladder urothelial carcinoma
Monocyte infiltration is an independent positive prognostic biomarker in vulvar squamous cell carcinoma
SPON1 is an independent prognostic biomarker for ovarian cancer
The role of matrix metalloproteinase-9 as a prognostic biomarker in papillary thyroid cancer
CXCL10 could be a prognostic and immunological biomarker in bladder cancer
CDH22 hypermethylation is an independent prognostic biomarker in breast cancer
Myosteatosis as a novel prognostic biomarker after radical cystectomy for bladder cancer
SIRT4 is an independent prognostic factor in bladder cancer and inhibits bladder cancer growth by suppressing autophagy
Identification of novel therapeutic target and prognostic biomarker in matrix metalloproteinase gene family in pancreatic cancer
Transcriptome sequencing identifies ANLN as a promising prognostic biomarker in bladder urothelial carcinoma
SKA3 is a prognostic biomarker and associated with immune infiltration in bladder cancer
Monocarboxylate Transporter 1 (MCT1) is an independent prognostic biomarker in endometrial cancer
PRR11 is a prognostic biomarker and correlates with immune infiltrates in bladder urothelial carcinoma